Macquarie Reaffirms Their Buy Rating on ALS Ltd. (CPBLF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 22 2024
0mins
Source: Business Insider
- Analyst Ratings and Price Targets: John Purtell from Macquarie maintained a Buy rating on ALS Ltd. with a price target of A$15.20, while Goldman Sachs also maintained a Buy rating with a A$15.60 price target.
- Financial Performance: ALS Ltd. reported a quarterly revenue of $25.2 billion and a GAAP net loss of $346 million for the quarter ending December 31, compared to last year's revenue of $21.79 billion and net profit of $1.12 billion.
- Analyst Consensus: The analyst consensus on ALS Ltd. is a Moderate Buy with an average price target of $9.10, indicating a 6.93% upside from current levels.
- Insider Activities: TipRanks tracked 36,000 company insiders and identified 3 stocks likely to make moves following their insider activities.
- Company Description: ALS Ltd. provides technical services in testing, measurement, inspection, and supporting across segments like Life Sciences, Industrial, Commodities, and Others. Founded in 1863, it is headquartered in Brisbane, Australia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
